Table 1.
The expression of EIF3G in CRC patients’ tissues (IHC)
| Cancer staging AJCC/UICC | n | EIF3G expression | P-Value# | ||||
|---|---|---|---|---|---|---|---|
|
| |||||||
| Negative | Weak | Moderate | Strong | ||||
| 0 | 31 | 18 | 10 | 2 | 1 | ||
| I | A | 21 | 10 | 7 | 4 | 0 | |
| B | 18 | 7 | 7 | 1 | 3 | ||
| C | 27 | 11 | 7 | 7 | 2 | ||
| II | A | 17 | 4 | 12 | 0 | 1 | |
| B | 16 | 10 | 1 | 3 | 2 | 0.286 | |
| C | 27 | 5 | 10 | 6 | 6 | ||
| III | A | 18 | 10 | 0 | 3 | 5 | |
| B | 19 | 6 | 4 | 5 | 4 | ||
| C | 28 | 9 | 4 | 7 | 8 | ||
| IV | A | 23 | 4 | 2 | 7 | 10 | |
| B | 19 | 5 | 3 | 8 | 3 | ||
#
The data was analyzed by the Kruskal-Wallis nonparametric one-way ANOVA followed by the Nemenyi pairwise multiple test.
P<0.05 was considered a significant different.